News
Since the Human Genome Project first produced the genetic instructions for a human being by sequencing DNA 22 years ago, ...
In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...
New module addresses multi-billion-dollar data quality challenge in life sciences by automating data cleansing, standardization, and transformation for AI readiness ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
The PocketMBA program embodies UD PCS’ commitment to equipping professionals with the skills necessary to excel in dynamic ...
NIST has released full genomic data from a pancreatic cancer cell line. This is the first cancer cell line developed from an ...
Drug discovery and development is a time-consuming and cost-intensive process. Computer-aided drug design can speed up the timeline and reduce costs by decreasing the number of necessary biochemical ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish about WGS stock.
5d
MyChesCo on MSNSlipstream Study Sheds Light on High Healthcare Costs and Unmet Needs in Rare Bleeding DisorderSlipstream has co-authored a landmark study on Hereditary Hemorrhagic Telangiectasia (HHT), offering the most comprehensive ...
The goals of this Perspective are threefold: (1) to inform a broad audience, including machine learning (ML) and artificial intelligence (AI) academics and professionals, about synthetic drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results